understand how radiopharmaceuticals treat metastatic prostate cancer How do new medications aid weight loss and why are they so effective?

The radiopharmaceuticals use radiation to kill prostate cancer cells.

lutetium-177 and radium-223

Both are given by intravenous injection, but they target the tumors in different ways.

Back

travels to bones, where the cancer has metastasized, and emits radiation that causes the tumor cells to die.

Radium-233

Bone

Prostate Cancer

Radium-233

The drug can also kill healthy cells, but because the radiation travels only a short distance, little surrounding tissue is damaged.

Back

throughout the body, attaching to tumors by binding to a protein in cancer cells called PSMA.

homes in on cancer

Lutetium-177

Back

Inside the cell,

releases radiation that kills the PSMA+ cell and nearby healthy cells.

Lutetium-177

Replay

can help people with metastatic prostate cancer live longer — and better — than expected without treatment.

lutetium-177 and radium-223

Both